深圳市海普瑞药业股份有限公司
制药业
Shenzhen,Guangdong 461 位关注者
Discover, develop, and commercialize high-quality, safe and effective medicines and services to address patients’ unmet
关于我们
Established in 1998 in Shenzhen, China, Hepalink is a leading multinational biopharmaceutical company dual-listed in Hong Kong and mainland China, with its core business in heparin industrial chain, large molecule biologics CDMO services, and the research, development, and commercialization of innovative drugs. These three synergistic business segments are driven by the mission of addressing patients’ unmet medical needs and bringing safe and effective therapies and services to patients around the world.
- 网站
-
http://www.hepalink.com
深圳市海普瑞药业股份有限公司的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Shenzhen,Guangdong
- 类型
- 上市公司
- 创立
- 1998
地点
-
主要
No.21 Langshan Road, Nanshan District
CN,Guangdong,Shenzhen,518057
深圳市海普瑞药业股份有限公司员工
-
Danuta (Danka) Andersen
Heparin Supply Chain / Global Supply Chain Division at Shenzhen Hepalink Pharmaceutical Co., Ltd.
-
Frances Huangmin
Sr Manager , Investment analyst at Shenzhen Hepalink Pharmaceutical Co., Ltd.
-
Andy Wu
Director of Internal Audit and internal control at Shenzhen Hepalink Pharmaceutical Co., Ltd.
-
Bei Liu
Intelligence Investigator and Assessor